https://www.selleckchem.com/pr....oducts/Myricetin(Can
Furthermore, this study also identified another potential therapeutic target, miR-433, for the treatment of myocardial ischemia-reperfusion injury. We present the results of 11 patients with hypochromic lesions treated with antifibrotic agents delivered through the MMP technique. Eleven patients with hypochromic lesions because of external injuries were treated at a single clinic with 5-fluorouracil (5-FU) and/or bleomycin using the MMP drug delivery technique. Treatment sessions were repeated at 30-day intervals until
Mi piace
Commento
Condividi
